(Picture perfect breakout + retest above)
Couple things to point out;
1B authorized, 189M shares Outstanding.
- Already selling in Indonesia, Turkey, Nigeria, Kenya, Bulgaria
-Plans to begin distribution into China, India, Russia, Poland, Hungry
-USA FDA approval is an 18 month+ project
-Product is superior cancer detection; painless, non-invasive with instant results. Sensitivity is much higher then current forms of testing.
Great long term play for a global company.
GLTAL
Couple things to point out;
1B authorized, 189M shares Outstanding.
- Already selling in Indonesia, Turkey, Nigeria, Kenya, Bulgaria
-Plans to begin distribution into China, India, Russia, Poland, Hungry
-USA FDA approval is an 18 month+ project
-Product is superior cancer detection; painless, non-invasive with instant results. Sensitivity is much higher then current forms of testing.
Great long term play for a global company.
GLTAL
Komen:
wrong chart... my mistake